PubRank

O Carpén

Author PubWeight™ 60.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000 2.25
2 ICAM-2 redistributed by ezrin as a target for killer cells. Nature 1996 2.04
3 Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 1998 2.01
4 Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol 1983 1.67
5 Mechanisms for regulating expression of membrane isoforms of Fc gamma RIII (CD16). Science 1989 1.63
6 Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell 2001 1.56
7 Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin. J Cell Biol 2000 1.56
8 Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum Mol Genet 1999 1.55
9 Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology 2003 1.47
10 The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. Cell Immunol 1981 1.40
11 Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet 1998 1.37
12 Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 1997 1.33
13 Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996 1.30
14 Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001 1.27
15 Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001 1.22
16 Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin. J Cell Sci 1999 1.22
17 The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol 1997 1.21
18 Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001 1.20
19 Natural killer cell and granulocyte Fc gamma receptor III (CD16) differ in membrane anchor and signal transduction. J Immunol 1989 1.13
20 Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 1996 1.11
21 EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer. Br J Cancer 2011 1.06
22 Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton. Oncogene 2007 1.02
23 VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 2000 0.99
24 Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to alpha-actinin. J Biol Chem 1996 0.99
25 Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 2001 0.99
26 Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein. Biochim Biophys Acta 1998 0.94
27 Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis. Neurology 2002 0.94
28 Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer 1999 0.94
29 Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment. Oncogene 2011 0.93
30 Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir (Wien) 2000 0.92
31 Membrane-proximal Ig-like domain of Fc gamma RIII (CD16) contains residues critical for ligand binding. J Immunol 1994 0.91
32 Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur J Immunol 2000 0.91
33 Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus. Neurology 2000 0.90
34 A functional association between merlin and HEI10, a cell cycle regulator. Oncogene 2006 0.90
35 Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 2004 0.89
36 Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure. Circulation 1997 0.88
37 Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures. Int J Cancer 1993 0.88
38 Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr 2000 0.87
39 Ezrin, a membrane-organizing protein, as a polarization marker of the retinal pigment epithelium in vertebrates. Cell Tissue Res 2000 0.86
40 Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation. Crit Care Med 1999 0.85
41 Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes. Eur J Immunol 1994 0.84
42 Activation of natural killer cell migration by leukocyte integrin-binding peptide from intracellular adhesion molecule-2 (ICAM-2). J Biol Chem 1995 0.84
43 Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors. Biochem Biophys Res Commun 1994 0.83
44 Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord 2003 0.83
45 Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-alpha. Mol Cell Endocrinol 1990 0.82
46 Developmental expression of myotilin, a gene mutated in limb-girdle muscular dystrophy type 1A. Mech Dev 2001 0.81
47 Generation of inositol phosphates during triggering of cytotoxicity in human natural killer and lymphokine-activated killer cells. Scand J Immunol 1989 0.78
48 Intercellular adhesion molecule-1 in extravasation of normal mononuclear and leukaemia cells. Br J Haematol 2001 0.78
49 Mechanism of cell contact-mediated inhibition of natural killer activity. J Immunol 1987 0.78
50 The role of microtubules in human natural killer cell-mediated cytotoxicity. Cell Immunol 1987 0.77
51 Identification and localization of urokinase-type plasminogen activator in human NK-cells. Int J Cancer 1986 0.77
52 The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer. Tumour Biol 1999 0.77
53 Mucin MUC1 is seen in cell surface protrusions together with ezrin in immunoelectron tomography and is concentrated at tips of filopodial protrusions in MCF-7 breast carcinoma cells. J Histochem Cytochem 2001 0.76
54 Fibromyxoma of the temporal bone. Otolaryngol Head Neck Surg 1997 0.76
55 Enhanced ICAM-1-dependent adhesion of myelomonocytic cells expressing increased levels of beta 2-integrins and CD43. Scand J Immunol 1994 0.76
56 Genomic structure of the human ezrin gene. Hum Genet 1998 0.76
57 Characteristics of soluble tumour-derived proteins that inhibit natural killer activity. Scand J Immunol 1988 0.75
58 Flow cytometric light scattering analysis, acrosome reaction, reactive oxygen species production and leukocyte contamination of semen preparation in prediction of fertilization rate in vitro. Hum Reprod 1998 0.75
59 Venous gangrene of the limb. Pathophysiological and therapeutic considerations. Ann Chir Gynaecol 1991 0.75
60 Flow cytometric analysis of semen preparation, and assessment of acrosome reaction, reactive oxygen species production and leucocyte contamination in subfertile men. Andrologia 1999 0.75
61 Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas. Acta Neurochir (Wien) 2003 0.75